华兰疫苗跌2.3% 2022年上市见顶募22.76亿元

Group 1 - The core point of the article is that Hualan Vaccine (301207.SZ) is currently trading at 19.14 yuan, reflecting a decline of 2.30% and is in a state of breaking its initial public offering price [1] - Hualan Vaccine was listed on the Shenzhen Stock Exchange's ChiNext board on February 18, 2022, with an initial public offering (IPO) price of 56.88 yuan per share and a total of 40.01 million shares issued [1][2] - On its first trading day, Hualan Vaccine reached a peak price of 79.78 yuan, indicating strong initial market interest [2] Group 2 - The total amount raised from the IPO was 2.276 billion yuan, with a net amount of 2.244 billion yuan after deducting issuance costs of 31.5657 million yuan [2] - The company planned to raise 2.495 billion yuan, which was 251 million yuan less than the actual amount raised, for various vaccine development and production projects [2] - The annual equity distribution plan for 2022 includes a cash dividend of 3.00 yuan for every 10 shares and a capital reserve increase of 5 shares for every 10 shares, with key dates for registration and ex-dividend set for June 6 and June 7, 2023, respectively [2]